Aprocitentan Now Available in the US for Treatment-Resistant Hypertension
Aprocitentan is the first-and-only dual endothelin receptor antagonist approved for the treatment of systemic hypertension.
FDA Accepts Dupilumab sBLA for Review for Treatment of Chronic Spontaneous Urticaria
The target action date for the FDA decision is April 18, 2025, according to Sanofi and Regeneron.
European Medicines Agency Reverses Opinion on Lecanemab for Alzheimer Disease But Limits Eligible Population
The EMA recommendation excludes from treatment adults who are homozygous for the ApoE ε4 gene, a decision that the US Alzheimer's Association does not support, said the president/CEO.
Risk Factors for Type 1 Diabetes: A Snapshot for Primary Care
About 40% of people who have T1D are not aware of it until they experience an extreme health event; screening in primary care can help reduce the risk, support families.
Semaglutide 2.4 mg Cuts Hospitalization Risk in CVD, Obesity: Daily Dose
Your daily dose of the clinical news you may have missed.
Nonpharmacologic Options for Agitation in Alzheimer Disease Should Always Come First: Expert Insights
Nondrug approaches to calming an adult with Alzheimer disease who is agitated should be prioritized over pharmacotherapy, geriatric psychiatrist George Grossberg, MD, counsels.
Environment is a Primary Nonpharmacologic Intervention to Reduce Agitation in Alzheimer Disease, Geriatric Psychiatrist Explains
When a patient with Alzheimer dementia becomes agitated, check the physical environment for a trigger before pulling the trigger on a medication, dementia expert George Grossberg, MD, recommends.
World Diabetes Day 2024: Diabetes Facts & Stats & a Call to Act
A quick review of the scope of diabetes in the US and of the gaps in equitable access to care supports the annual call to action from the International Diabetes Federation.
7 Questions on US STI Trends
The CDC just released its annual STD surveillance report. Are you caught up on the latest trends? Try your hand at these 7 questions to find out.
GLP-1RAs Cut Early Colorectal Cancer Risk in Adults with T2D: Daily Dose
STI Epidemic in US Shows Signs of Slowing, According to New CDC Report
More than 2.4 million STIs were reported in the US in 2023 — a 1.8% decrease from 2022, according to the CDC's annual STI report.
Pandemic Medical Misinformation Has Not Prompted Disciplinary Action, Study Reveals
Little action has been taken by state medical boards against clinicians who spread unsubstantiated claims about COVID-19, vaccines, or other pandemic-related topics.
Alzheimer Disease Insights: It's Not All About Cognition, Counsels George Grossberg, MD
The geriatric psychiatrist refers in this interview to agitation in Alzheimer disease, a significant neuropsychiatric symptom that should not be dismissed.
Adjusted Donanemab Dosing Lowers ARIA-E Risk in Early Alzheimer Disease: Daily Dose
Obstructive Sleep Apnea Linked to Increased Risk for Dementia, Particularly in Women
Michigan Medicine researchers found that at all age levels, women with known/suspected OSA were more likely than men to be diagnosed with dementia.
FDA Lifts Clinical Hold on Novavax’s COVID-19-Influenza Combination Vaccine
The FDA cleared Novavax to start enrolling the planned phase 3 trial after a safety concern was found to be unrelated to the combination vaccine.
11 Things You Should NOT Say to Patients: How to Replace the "Never-Words"
The 11 words and phrases, among others, are often automatic responses from clinicians in highly emotional settings of severe illness. Find 11 alternatives, here.
Patient Perspectives on Colonoscopies: Daily Dose
November Issue of Patient Care Online Digital Edition is Now Live
Find details on the surge in US pertussis cases, the first self-administered flu vaccine, and study findings underscoring the evolving nature of long COVID.
Death Rates from Obesity-Related Heart Disease Soared Nearly 200% Between 1990 and 2020, Researchers Report
AHA 2024. "...we did not anticipate this magnitude of increase in mortality," researchers said. They were also surprised by the population groups most affected.
